Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors

Author： Xiao Zhan Xue John Gu Wen-Zhen Bui Mai Li Gaoquan Tao Zhi-Fu Lin Nan-Horng Sowin Thomas Zhang Haiying

ISSN： 1366-5804

Source： Biomarkers, Vol.13, Iss.6, 2008-09, pp. : 579-596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Response of the Human Cyclin B1 Promoter to Inhibitors of the Cell Cycle in NIH3T3 Cells

By Nuckolls F.J. Khan A.S. Butler R. Katula K.S.

Biochemical and Biophysical Research Communications, Vol. 244, Iss. 1, 1998-03 ,pp. : 280-284

Elsevier

Access to resources Recommend Favorite

The position of Chk1 in cancer research

By Golsteyn R.M.

Trends in Cell Biology, Vol. 11, Iss. 5, 2001-05 ,pp. : 191-191

Elsevier

Access to resources Recommend Favorite

AIRE1A might be involved in cyclin B2 degradation in testicular lysates

By Brahmaraju M. Bhagya K.P. Titus Shiny Sebastian Arun Devi A.N. Laloraya Malini Kumar Pradeep G.

Biochemistry and Cell Biology, Vol. 89, Iss. 4, 2011-08 ,pp. : 411-422

NRC Research Press

Access to resources Recommend Favorite

Evidence for reciliation of RPE1 cells in late G1 phase, and ciliary localisation of cyclin B1

FEBS Open Bio, Vol. 3, Iss. 1, 2013-01 ,pp. : 334-340

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1

By Annaert P. Ye Z.W. Stieger B. Augustijns P.

Xenobiotica, Vol. 40, Iss. 3, 2010-03 ,pp. : 163-176

Informa Healthcare

Access to resources Recommend Favorite